Located in Jiangsu Medpark, Suzhou New District, Sandstone Medical concentrates on the R&D, production, and marketing of
insulin self-injection consumables for people with diabetes, providing safe, home-use solutions that support daily glucose management. Since its founding in 2018, the company has achieved ISO 13485 certification, EU CE marking, U.S. FDA 510(k) registration, Medical Device Single Audit Program (MDSAP) approval, ANVISA clearance in Brazil, and Japan’s Foreign Manufacturer Registration (FMR) under the PMD Act.
